The US Food and Drug Administration (FDA) has banned Pax-All Manufacturing from shipping its drugs to the US market, until it cleans up its alleged shoddy manufacturing practices.
Subscribe to our email newsletter
FDA reported that the facility is failing to perform adequate product testing and is practicing inadequate labelling or documentation of its drug products, The Globe And Mail reported.
The company was found to have no testing program to assess proper storage conditions or expiry dates.
FDA spokeswoman Shelly Burgess was quoted by the news agency as saying that it takes a risk-based approach depending on the level of risk involved and how severe the potential violation would be to the consumer.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.